1. Pathogenesis and Potential Therapeutic Targets for Triple-Negative Breast Cancer
   Chia-Jung Li et al, 2021, Cancers CrossRef
2. Necroptosis-Related LncRNAs Signature and Subtypes for Predicting Prognosis and Revealing the Immune Microenvironment in Breast Cancer
   Yuhao Xu et al, 2022, Frontiers in Oncology CrossRef
3. Prognostic significance of programmed death-1 and programmed death ligand-1 proteins in breast cancer
   Imtiaz Mahmood Tahir et al, 2022, Human Antibodies CrossRef
4. Molecular Classification, Treatment, and Genetic Biomarkers in Triple-Negative Breast Cancer: A Review
   Boya Lu et al, 2023, Technology in Cancer Research & Treatment CrossRef
5. Molecular and serological biomarkers to predict trastuzumab responsiveness in HER-2 positive breast cancer
   Loma Al-Mansouri et al, 2023, Journal of Medicine and Life CrossRef
6. Tissue Selection for PD-L1 Testing in Triple Negative Breast Cancer (TNBC)
   Florin Dobritoiu et al, 2022, Applied Immunohistochemistry & Molecular Morphology CrossRef
7. Tumor necroptosis-mediated shedding of cell surface proteins promotes metastasis of breast cancer by suppressing anti-tumor immunity
   Zhaoshan Liu et al, 2023, Breast Cancer Research CrossRef
8. Enabling continuous immune cell recirculation on a microfluidic array to study immunotherapeutic interactions in a recapitulated tumour microenvironment
   Chun-Wei Chi et al, 2024, Lab on a Chip CrossRef
9. Programmed death-ligand 1 expression in carcinoma of unknown primary
   Hye Min Kim et al, 2024, BMC Cancer CrossRef
10. An overview of the therapeutic strategies for neoplastic meningitis due to breast cancer: when and why?
    Mainak Bardhan et al, 2024, Expert Review of Neurotherapeutics CrossRef
11. Multi-Omics Reveals the Immunological Role and Prognostic Potential of Mitochondrial Ubiquitin Ligase MARCH5 in Human Breast Cancer
    Pei-Yi Chu et al, 2021, Biomedicines CrossRef
12. Integrated analysis of pivotal biomarker of LSM1, immune cell infiltration and therapeutic drugs in breast cancer
    Yen‐Dun Tony Tzeng et al, 2022, Journal of Cellular and Molecular Medicine CrossRef
13. Enhancement of anti-tumor efficacy of immune checkpoint blockade by alpha-TEA
    William L. Redmond et al, 2023, Frontiers in Immunology CrossRef
14. Association of GATA3 expression in triple-positive breast cancer with overall survival and immune cell infiltration
    Xiuwen Chen et al, 2024, Scientific Reports CrossRef
15. Sprod for de-noising spatially resolved transcriptomics data based on position and image information
    Yunguan Wang et al, 2022, Nature Methods CrossRef
16. The role of LSM1 in breast cancer: Shaping metabolism and tumor-associated macrophage infiltration
    Yen-Dun Tony Tzeng et al, 2023, Pharmacological Research CrossRef
17. Non-viral vector-based genome editing for cancer immunotherapy
    Tianxu Fang et al, 2024, Biomaterials Science CrossRef
18. Downregulation of ATP binding cassette subfamily a member 10 acts as a prognostic factor associated with immune infiltration in breast cancer
    Pei-Yi Chu et al, 2022, Aging CrossRef
19. Cuproptosis key gene FDX1 is a prognostic biomarker and associated with immune infiltration in glioma
    Hanwen Lu et al, 2022, Frontiers in Medicine CrossRef